-
1.发明申请NOVEL BIAROMATIC COMPOUNDS THAT MODULATE PPARY TYPE RECEPTORS AND COSMETIC/PHARMACEUTICAL COMPOSITIONS COMPRISED THEREOF 审中-公开调节PPAR类型受体的新型BIAROMATIC化合物及其包含的化妆品/药物组合物公开(公告)号：US20130303549A1
公开(公告)日：2013-11-14
申请号：US13939153
申请日：2013-07-10
Applicant: Galderma Research & Development
Inventor： Jean-Guy BOITEAU , Laurence CLARY , Corinne Millois BARBUIS
IPC: C07D333/24 , C07D213/55 , C07D307/54 , C07D239/26
CPC classification number: C07D333/24 , C07D213/55 , C07D213/75 , C07D239/26 , C07D239/42 , C07D307/54
Abstract: Novel biaromatic compounds having the general formula (I): and cosmetic/pharmaceutical compositions comprised thereof are useful in human or veterinary medicine (in dermatology and also in the fields of cardiovascular diseases, of immune diseases and/of diseases related to the metabolism of lipids), or, alternatively, in cosmetic compositions.
Abstract translation: 具有通式（I）的新型双芳族化合物及其包含的化妆品/药物组合物可用于人或兽医学（在皮肤病学领域以及心血管疾病，免疫疾病和/或与脂质代谢有关的疾病领域 ），或者在化妆品组合物中。
-
2.发明申请DISUBSTITUTED 3,4-DIAMINO-3-CYCLOBUTENE-1,2-DIONE COMPOUNDS FOR USE IN THE TREATMENT OF CHEMOKINE-MEDIATED PATHOLOGIES 有权用于治疗介导性病理学的3,4-DIAMINO-3-CYCLOBUTENE-1,2-DIONE化合物公开(公告)号：US20150374708A1
公开(公告)日：2015-12-31
申请号：US14668723
申请日：2015-03-25
Applicant: GALDERMA RESEARCH & DEVELOPMENT
Inventor： Branislav MUSICKI , Jerôme AUBERT , Jean-Guy BOITEAU , Laurence CLARY , Patricia ROSSIO , Marlène SCHUPPLI-NOLLET
IPC: A61K31/5377 , A61K31/4025 , A61K31/4035 , A61K31/506 , A61K31/496 , A61K31/443 , A61K31/423 , A61K31/397 , A61K31/381 , A61K31/341 , A61K31/4709
CPC classification number: A61K31/5377 , A61K31/341 , A61K31/351 , A61K31/381 , A61K31/397 , A61K31/4015 , A61K31/4025 , A61K31/4035 , A61K31/4184 , A61K31/4192 , A61K31/422 , A61K31/423 , A61K31/4427 , A61K31/443 , A61K31/4709 , A61K31/496 , A61K31/506 , C07D405/06 , C07D405/14 , C07D407/06 , C07D407/14 , C07D409/14 , C07D413/14
Abstract: Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds represented by the general formula (I) are described. Also described, are pharmaceutical compositions including these compounds and the use of these compounds and compositions for the treatment of chemokine-mediated pathologies.
Abstract translation: 描述由通式（I）表示的二取代的3,4-二氨基-3-环丁烯-1,2-二酮化合物。 还描述了包括这些化合物的药物组合物以及这些化合物和组合物用于治疗趋化因子介导的病理学的用途。
-
3.发明申请NOVEL BENZENESULFONAMIDE COMPOUNDS, METHOD FOR SYNTHESIZING SAME, AND USE THEREOF IN MEDICINE AS WELL AS IN COSMETICS 有权新型苯并噻二唑化合物，其合成方法及其在医药中的用途如同化妆品公开(公告)号：US20150158834A1
公开(公告)日：2015-06-11
申请号：US14626302
申请日：2015-02-19
Applicant: GALDERMA RESEARCH & DEVELOPMENT
Inventor： Laurence CLARY , Sandrine CHAMBON , Laurent CHANTALAT , Carine ROSIGNOLI , Olivier ROYE , Jean-Claude PASCAL , Marlene SCHUPPLI-NOLLET
IPC: C07D295/26 , C07D471/04 , C07D209/26 , C07D261/20 , C07D215/14 , C07D213/68
CPC classification number: C07D215/14 , A61K31/4965 , A61K31/497 , A61K31/551 , C07D209/10 , C07D209/12 , C07D209/20 , C07D209/24 , C07D209/26 , C07D213/30 , C07D213/55 , C07D213/56 , C07D213/68 , C07D261/20 , C07D295/15 , C07D295/26 , C07D471/04 , Y02A50/411
Abstract: Benzenesulfonamide compounds having a structure of formula (I) are described. Also described, are methods for synthesizing the compounds and to the use thereof in pharmaceutical compositions for human or veterinary medicine and in cosmetic compositions.
Abstract translation: 描述具有式（I）结构的苯磺酰胺化合物。 还描述了用于合成化合物的方法及其在人或兽医学药物组合物和化妆品组合物中的用途。
-
4.发明申请NOVEL DISUBSTITUTED 3,4-DIAMINO-3-CYCLOBUTENE-1,2-DIONE COMPOUNDS FOR USE IN THE TREATMENT OF CHEMOKINE-MEDIATED DISEASES 有权新型分离的3,4-DIAMINO-3-CYCLOBUTENE-1,2-Dione化合物用于治疗介导性疾病公开(公告)号：US20160362403A1
公开(公告)日：2016-12-15
申请号：US15175363
申请日：2016-06-07
Applicant: GALDERMA RESEARCH & DEVELOPMENT
Inventor： Branislav MUSICKI , Jerôme AUBERT , Jean-Guy BOITEAU , Laurence CLARY , Patricia ROSSIO , Marlène SCHUPPLI-NOLLET
IPC: C07D409/14 , C07D409/06 , C07D307/16 , C07D407/06
CPC classification number: C07D409/14 , A61K31/341 , A61K31/381 , A61K31/4025 , C07D307/14 , C07D307/16 , C07D307/54 , C07D407/06 , C07D409/06
Abstract: Methods for preparing disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds that correspond to general formula (I) are described. Also described are pharmaceutical compositions that include the compounds, and methods of using the compounds and compositions for the treatment of chemokine-mediated diseases.
Abstract translation: 描述了制备对应于通式（I）的二取代的3,4-二氨基-3-环丁烯-1,2-二酮化合物的方法。 还描述了包括化合物的药物组合物，以及使用化合物和组合物治疗趋化因子介导的疾病的方法。
-
5.发明申请公开(公告)号：US20160280650A1
公开(公告)日：2016-09-29
申请号：US15173173
申请日：2016-06-03
Applicant: GALDERMA RESEARCH & DEVELOPMENT
Inventor： Laurence CLARY , Sandrine CHAMBON , Laurent CHANTALAT , Carine ROSIGNOLI , Olivier ROYE , Jean-Claude PASCAL , Marlene SCHUPPLI-NOLLET
IPC: C07D215/14 , C07D471/04 , C07D209/12 , C07D261/20 , C07D295/26 , C07D213/30
CPC classification number: C07D215/14 , A61K31/4965 , A61K31/497 , A61K31/551 , C07D209/10 , C07D209/12 , C07D209/20 , C07D209/24 , C07D209/26 , C07D213/30 , C07D213/55 , C07D213/56 , C07D213/68 , C07D261/20 , C07D295/15 , C07D295/26 , C07D471/04 , Y02A50/411
Abstract: Benzenesulfonamide compounds having a structure of formula (I) are described. Also described, are methods for synthesizing the compounds and to the use thereof in pharmaceutical compositions for human or veterinary medicine and in cosmetic compositions.
-
Patent Agency Ranking
公开(公告)号：US20130172363A1
公开(公告)日：2013-07-04
申请号：US13774023
申请日：2013-02-22
Applicant: Galderma Research & Development
Inventor： Laurence CLARY , Sandrine CHAMBON , Laurent CHANTALAT , Carine ROSIGNOLI , Olivier ROYE , Jean-Claude PASCAL , Marlene SCHUPPLI
IPC: C07D295/15 , C07D471/04 , C07D209/24 , C07D261/20 , C07D215/14 , C07D213/55
CPC classification number: C07D215/14 , A61K31/4965 , A61K31/497 , A61K31/551 , C07D209/10 , C07D209/12 , C07D209/20 , C07D209/24 , C07D209/26 , C07D213/30 , C07D213/55 , C07D213/56 , C07D213/68 , C07D261/20 , C07D295/15 , C07D295/26 , C07D471/04 , Y02A50/411
Abstract: Benzenesulfonamide compounds having a structure of formula (I) are described. Also described, are methods for synthesizing the compounds and to the use thereof in pharmaceutical compositions for human or veterinary medicine and in cosmetic compositions.
-
公开(公告)号：US20200317683A1
公开(公告)日：2020-10-08
申请号：US16907122
申请日：2020-06-19
Applicant: GALDERMA RESEARCH & DEVELOPMENT
Inventor： Laurence CLARY , Jean-François FOURNIER , Gilles OUVRY , Yushma BHURRUTH-ALCOR , Etienne THOREAU , Loïc TOMAS
IPC: C07D487/20 , A61K9/00 , C07D487/04
Abstract: The invention relates to novel mTOR inhibitor compounds. The invention is characterized in that the mTOR inhibitor compounds have general formula (I). The invention also relates to compositions comprising said mTOR inhibitor compounds, methods for producing same, and the use thereof in compositions as a drug.
-
公开(公告)号：US20200317679A1
公开(公告)日：2020-10-08
申请号：US16907154
申请日：2020-06-19
Applicant: GALDERMA RESEARCH & DEVELOPMENT
Inventor： Laurence CLARY , Jean-François FOURNIER , Gilles OUVRY , Yushma BHURRUTH-ALCOR , Etienne THOREAU , Loïc TOMAS
IPC: C07D487/04 , A61K9/00 , C07D519/00
Abstract: The invention relates to novel mTOR inhibitor compounds. The invention is characterized in that the mTOR inhibitor compounds have general formula (I). The invention also relates to compositions comprising said mTOR inhibitor compounds, methods for producing same, and the use thereof in compositions as a drug.
-
9.发明申请DISUBSTITUTED 3,4-DIAMINO-3-CYCLOBUTENE-1,2-DIONE COMPOUNDS FOR USE IN THE TREATMENT OF CHEMOKINE-MEDIATED DISEASES 有权用于治疗介导性疾病的3,4-DIAMINO-3-CYCLOBUTENE-1,2-DIONE化合物公开(公告)号：US20160166562A1
公开(公告)日：2016-06-16
申请号：US14707551
申请日：2015-05-08
Applicant: GALDERMA RESEARCH & DEVELOPMENT
Inventor： Branislav MUSICKI , Jerôme AUBERT , Patricia ROSSIO , Marlène SCHUPPLI-NOLLET , Laurence CLARY , Jean-Guy BOITEAU
IPC: A61K31/4525 , A61K31/382 , A61K31/351
CPC classification number: A61K31/4525 , A61K31/351 , A61K31/382 , C07D405/06 , C07D407/06 , C07D409/06
Abstract: Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds corresponding to general formula (I) are disclosed. Also disclosed, are pharmaceutical compositions including these compounds and methods of using these compounds and compositions for the treatment of chemokine-mediated diseases.
Abstract translation: 公开了对应于通式（I）的二取代的3,4-二氨基-3-环丁烯-1,2-二酮化合物。 还公开了包括这些化合物的药物组合物和使用这些化合物和组合物治疗趋化因子介导的疾病的方法。
-
10.发明申请NOVEL BENZENESULFONAMIDE COMPOUNDS, METHOD FOR SYNTHESIZING SAME, AND USE THEREOF IN MEDICINE AS WELL AS IN COSMETICS 有权新型苯并噻二唑化合物，其合成方法及其在医药中的用途如同化妆品公开(公告)号：US20140107129A1
公开(公告)日：2014-04-17
申请号：US14103470
申请日：2013-12-11
Applicant: Galderma Research & Development
Inventor： Laurence CLARY , Sandrine CHAMBON , Laurent CHANTALAT , Carine ROSIGNOLI , Olivier ROYE , Jean-Claude PASCAL , Marlene SCHUPPLI-NOLLET
IPC: C07D471/04 , C07D295/15 , C07D261/20 , C07D209/20 , C07D213/56 , C07D215/14
CPC classification number: C07D215/14 , A61K31/4965 , A61K31/497 , A61K31/551 , C07D209/10 , C07D209/12 , C07D209/20 , C07D209/24 , C07D209/26 , C07D213/30 , C07D213/55 , C07D213/56 , C07D213/68 , C07D261/20 , C07D295/15 , C07D295/26 , C07D471/04 , Y02A50/411
Abstract: Benzenesulfonamide compounds having a structure of formula (I) are described. Also described, are methods for synthesizing the compounds and to the use thereof in pharmaceutical compositions for human or veterinary medicine and in cosmetic compositions.
Abstract translation: 描述具有式（I）结构的苯磺酰胺化合物。 还描述了用于合成化合物的方法及其在人或兽医学药物组合物和化妆品组合物中的用途。
-
-
-
-
-
-
-
-
-
Search Results
10
records
(took 0.019 seconds)
